Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis.
Montecucco F, Bondarenko AI, Lenglet S, Burger F, Piscitelli F, Carbone F, Roth A, Liberale L, Dallegri F, Brandt KJ, Fraga-Silva RA, Stergiopulos N, Di Marzo V, Mach F.
Montecucco F, et al. Among authors: brandt kj.
Thromb Haemost. 2016 Oct 28;116(5):987-997. doi: 10.1160/TH16-02-0139. Epub 2016 Jul 28.
Thromb Haemost. 2016.
PMID: 27465665